Le Lézard
Classified in: Health
Subject: SVY

United States Interventional Cardiology Market Overview 2018: Angiography Procedure Volume is Expected to Remain Stable


DUBLIN, July 18, 2018 /PRNewswire/ --

The "US Market Overview for Interventional Cardiology 2018 - MedView" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Following several years of substantial declines, percutaneous coronary intervention (PCI) procedure volume has recently stabilized, and is expected to grow at low single digits over the forecast period. Procedure growth exhibits a positive effect on the associated device markets, such as stents, balloon catheters, interventional catheters and guidewires and various other devices required per procedure. Angiography procedure volume is also expected to remain stable over the forecast period.
Key Topics Covered:

EXECUTIVE SUMMARY
U.S. Interventional Cardiology Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. RESEARCH METHODOLOGY

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics

3. BALLOON-INFLATION DEVICE MARKET
3.1 INTRODUCTION
3.2 MARKET ANALYSIS AND FORECAST
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX I: COMPANY PRESS RELEASES

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/4f85q9/united_states?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 19:40
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
Greenberg Traurig's David Dykeman and Roman Fayerberg to Present at DeviceTalks Boston
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance Provides Notice Following Data Security Incident
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
CHEMISTREE DEBENTUREHOLDERS APPROVE DEBT RESTRUCTURING
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Public Advisory - Fake Viagra seized from Jug City store in Scarborough, ON
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

More news about Health...


News published on and distributed by: